Abbreviations	Meaning
3D	3-dimensional
Ab	antibody
ADC	antibody-drug conjugate
AP-1	activator protein 1
AUC	area under the curve
Cl	clearance
CPM	counts per minute
CR	complete regressor
CT	computed tomography
DAR	drug-to-antibody ratio
DFO	deferoxamine
DOL	degree of labeling
FMT	fluorescence molecular tomography
HC	heavy chain
HPLC-MS	high performance liquid chromatography–mass spectrometry
IC50	half-maximal inhibitory concentration
ID	injected dose
ID/g	injected dose per gram
IL13	interleukin 13
IR	immuno-reactivity
IV	intravenous, intravenously
JAK	janus kinases
LC	light chain
mAb	monoclonal Ab
MAPK	mitogen-activated protein kinase
MIP	Maximum Intensity Projection
PBS	phosphate-buffered saline
PET	positron emission tomography
PK	pharmacokinetics
PKB	protein kinase B
q4d	every 4 days
QC	quality control
R	receptor
ROI	region of interest
SEC	size exclusion chromatography
SEM	standard error of the mean
SNR	signal-to-noise ratio
SPECT	single photon emission computed tomography
STAT	signal transducer and activator of transcription proteins
T/C	Tumor/control
t1/2	half-life
TGF	transforming growth factor
TNF	tumor necrosis factor
Zr	zirconium